Arkansas alleges insulin pricing plot involving Novo Nordisk, Eli Lilly and Sanofi

Arkansas Attorney General Leslie Rutledge has filed a complaint alleging that the insulin makers have colluded with a group of pharmacy benefit managers, including Express Scripts, to raise insulin prices and pay back the PBMs in discounts.
Arkansas Attorney General Leslie Rutledge | Photo: Staci R. Vandagriff/AP/Ritzau Scanpix
Arkansas Attorney General Leslie Rutledge | Photo: Staci R. Vandagriff/AP/Ritzau Scanpix
by andreas lønstrup, translated by daniel pedersen

The State of Arkansas has filed a complaint against Novo Nordisk, Eli Lilly, and Sanofi – all makers of the insulin supplying the state – as well as a group of pharmacy benefit managers (PBMs) that dominate the insulin pricing system there, including Express Scripts, which is the biggest PBM in the US.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading